The ability of Candida spp. to form biofilms is crucial for its pathogenicity, and thus, it should
be considered an important virulence factor in vulvovaginal candidiasis (VVC) and recurrent …

The emergence of new fungal pathogens makes the development of new antifungal drugs a
medical imperative that in recent years motivates the talents of numerous investigators …

A pH-responsive hydrogel having a drug combined effect was prepared for wound dressing
by using dialdehyde carboxymethyl cellulose, tobramycin, β-cyclodextrin derivative and …

The presence of fungal infections continue to grow worldwide, mostly in immunosuppressed
patients, and in individuals with continued antimicrobial treatments. Candida spp. are the …

Fungi cause serious nosocomial infections including candidiasis and aspergillosis, some of
which display reduced susceptibility to current antifungals. Inorganic compounds have been …

Resistance to aminoglycoside antibiotics is a serious problem, typically arising from
inactivating enzymes, reduced uptake, or increased efflux in the important pathogens for …

Fungal infections are a growing challenge in immunocompromised patients, especially
candidiasis. The prolonged use of traditional antifungals to treat Candida infection has …

Objectives: Aminoglycosides are one of the first classes of natural antibiotics which have not
lost relevance due to their broad spectrum of action against Gram-positive, Gram-negative …

Abstract Commercially available dichloro [2, 2′-bis (diphenylphosphino)-1, 1′-binaphthyl]
palladium (II)(BINAP. PdCl2) homogeneous catalyst was used for the reduction of aryl …

Development of novel therapeutics to treat antibiotic-resistant infections, especially those
caused by ESKAPE pathogens, is urgent. One of the most critical pathogens is P …